Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jan. 31, 2015	Jan. 31, 2014	Jan. 31, 2013
Operating activities:
Net loss	$ (12,011,457)	$ (11,717,190)	$ (5,378,729)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities, net of effect of acquisitions:
Depreciation	1,005,283	718,097	726,406
Amortization of capitalized software development costs	3,677,991	3,192,157	2,659,365
Amortization of intangible assets	1,396,317	1,341,734	583,535
Amortization of other deferred costs	189,107	385,461	241,478
Amortization of debt discount	47,552	4,327	111,583
Valuation adjustment for warrants liability	(2,283,345)	(140,928)	(489,434)
Deferred tax expense (benefit)	(720,582)	20,885	(2,935,522)
Valuation adjustment for contingent earn-out	0	3,580,441	86,839
Other valuation adjustments	128,855	(95,368)	0
Net loss from conversion of convertible notes	0	0	5,970,002
Loss on impairment of intangible assets	1,952,000	0	0
Loss from early extinguishment of debt	315,327	160,713	0
Loss on disposal of fixed assets	180,793	0	0
Loss on exit of operating lease	234,823	0	0
Share-based compensation expense	1,934,298	1,660,598	956,144
Provision for accounts receivable	440,771	330,907	67,464
Changes in assets and liabilities, net of assets acquired:
Accounts and contract receivables	2,157,977	827,435	(2,923,242)
Other assets	(637,348)	(439,477)	(1,129,255)
Accounts payable	600,263	275,360	526,149
Accrued expenses	(1,422,571)	259,771	992,285
Deferred revenues	(197,698)	(152,210)	(180,200)
Net cash (used in) provided by operating activities	(3,011,644)	212,713	(115,132)
Investing activities:
Purchases of property and equipment	(2,125,240)	(152,283)	(576,736)
Capitalization of software development costs	(619,752)	(614,028)	(1,999,676)
Payment for acquisition, net of cash acquired	(6,058,225)	(3,000,000)	(12,161,614)
Net cash used in investing activities	(8,803,217)	(3,766,311)	(14,738,026)
Financing activities:
Proceeds from term loan	10,000,000	4,958,333	9,880,000
Principal repayments on term loans	(8,297,620)	(10,348,214)	(312,500)
Principal repayments on note payable	(900,000)	0	0
Principal payments on capital lease obligation	(368,386)	(34,391)	0
Payment of deferred financing costs	(573,002)	(115,900)	(1,271,862)
Proceeds from private placement	0	0	12,000,000
Proceeds from exercise of stock options and stock purchase plan	551,583	1,356,060	282,628
Settlement of earn-out consideration	0	(1,300,000)	0
Proceeds from the sale of common stock	0	20,586,619	0
Payment of debt success fee	0	(1,124,279)	(467,906)
Net cash provided by financing activities	412,575	13,978,228	20,110,360
(Decrease) increase in cash and cash equivalents	(11,402,286)	10,424,630	5,257,202
Cash and cash equivalents at beginning of year	17,924,886	7,500,256	2,243,054
Cash and cash equivalents at end of year	6,522,600	17,924,886	7,500,256
Supplemental cash flow disclosures:
Interest paid	518,919	2,422,997	1,626,750
Income taxes (received) paid	(80,467)	375,688	84,990
Conversion of $3,000,000 note payable to common shares	0	0	3,116,182
Conversion of 1,050,000 shares of Series A Preferred Stock to common shares	0	3,150,000	0
Issuance of 393,086 shares of common stock, as part of Meta purchase price	0	0	1,501,609
Issuance of 400,000 shares of common stock, as part of settlement of earn-out consideration	0	2,700,000	0
Issuance of $900,000 note payable as part of settlement of earn-out consideration	0	900,000	0
Deemed dividends on Series A Preferred Stock	1,038,310	1,180,904	176,048
Issuance of warrants to placement agents	0	0	753,737
Reclassification of warrants from equity to warrants liability	0	0	4,138,783
Conversion of notes issued in conjunction with the private placement to Series A Preferred Stock, at fair value	0	0	9,182,652
Interest rate swap contract	$ 0	$ 111,086	$ 0